Insight Guru Inc.
08/20/2026 | Press release | Distributed by Public on 08/20/2026 03:23
The 52-Week-High List: 18 Large Cap Names On Wednesday
A narrow list of market leaders suggests strength is highly concentrated in one part of the economy.
As of Wednesday, 18 Large Cap stocks from the Russell 3000 are trading at their 52-week highs. This is a remarkably narrow list, dominated by a single theme: of those 18 names, 13 are from the Health Care sector. The largest company on the list is Eli Lilly (LLY).
With a one-month run like Moderna's (MRNA) 192.3% gain on the same list where the S&P 500 returned +2.8%, the central question is whether the underlying business justifies the price. The 10 largest of these names are below.
The 10 Largest, By Market Cap
The table below shows the 10 largest of the 18 names, sorted by market capitalization, with returns over four windows:
| Tickers |
Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| LLY | $1,145.26 Bil | 4.5% | 5.1% | 9.1% | 84.6% |
| JNJ | $658.21 Bil | 0.8% | 4.8% | 9.1% | 59.0% |
| ABBV | $470.77 Bil | 2.7% | 6.9% | 3.9% | 32.7% |
| KO | $388.69 Bil | 1.7% | 4.2% | 10.2% | 34.4% |
| MRK | $376.24 Bil | 12.6% | 14.5% | 20.5% | 86.8% |
| AMGN | $238.87 Bil | 4.0% | 6.3% | 20.8% | 55.7% |
| PFE | $160.71 Bil | 3.6% | 7.3% | 15.2% | 20.5% |
| VRTX | $140.28 Bil | 4.5% | 5.0% | 14.5% | 41.6% |
| BMY | $137.79 Bil | 2.4% | 6.1% | 11.0% | 47.0% |
| ABNB | $111.46 Bil | 1.7% | 3.5% | 29.3% | 48.5% |
Which of these giants are earning their new highs?
Eli Lilly (LLY) presents a case where the business is keeping pace. Its revenue grew 49.6% over the last twelve months, with an operating margin of 49.7%. The stock trades at 42.8 times trailing earnings.
Contrast that with AbbVie (ABBV), another name from the Health Care sector on the list. Its stock trades at 74.6 times trailing earnings, while its revenue grew 10.4% over the last twelve months with a 33.9% operating margin.
So is a 52-week high a buy signal?
Strength often persists, and a stock at its high is by definition a winning trade. But a price is not a verdict on the business itself. A 52-week-high list is best used as a starting point for research, not a finish line.
The disciplined move is to ask if the company's growth and profitability can support its current valuation. The list shows what is working; your work is to find out why, and if it can continue.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks, which is the momentum that tends to have staying power.
One more pattern worth noticing: 13 of the 18 names are Health Care stocks. When a whole group is making new highs together, a healthcare ETF like XLV is one way to own the group's strength without betting on which single name leads it from here.
New Highs Fade. Discipline Compounds
Some of the names on this list will keep setting highs for years, and some are at the top of their run right now. Sorting one from the other, name by name, every day, is the work most investors never keep up with.
That sorting is what the Trefis High Quality (HQ) Portfolio does systematically: about 30 quality businesses screened for the fundamentals that sustain a run, held with rules instead of excitement. It has a track record of outpacing a benchmark that combines the three major indices - the S&P 500, S&P Mid-cap, and Russell 2000. Use the high list for ideas; use the portfolio for the compounding.
Insight Guru Inc. published this content on August 20, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 20, 2026 at 09:24 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]